DISTINGUISHED INVESTIGATOR OF THERANOSTICS Trademark
Trademark Overview
On Tuesday, November 5, 2024, a trademark application was filed for DISTINGUISHED INVESTIGATOR OF THERANOSTICS with the United States Patent and Trademark Office. The USPTO has given the DISTINGUISHED INVESTIGATOR OF THERANOSTICS trademark a serial number of 98838242. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, September 2, 2025. This trademark is owned by Xcancer Software, LLC. The DISTINGUISHED INVESTIGATOR OF THERANOSTICS trademark is filed in the category with the following description:
Medical research in the field of investigational radioligand therapies and imaging
General Information
Serial Number | 98838242 |
Word Mark | DISTINGUISHED INVESTIGATOR OF THERANOSTICS |
Filing Date | Tuesday, November 5, 2024 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Tuesday, September 2, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medical research in the field of investigational radioligand therapies and imaging |
Certification Mark Statement | The certification mark, as used by persons authorized by the certifier, certifies that the provider of services has demonstrated a mastery of conducting novel radioligand therapies and molecular imaging clinical trials. |
Classification Information
International Class | B - |
US Class Codes | B |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 5, 2024 |
Primary Code | B |
First Use Anywhere Date | Tuesday, April 30, 2024 |
First Use In Commerce Date | Tuesday, April 30, 2024 |
Trademark Owner History
Party Name | Xcancer Software, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Omaha, NE 68130 |
Trademark Events
Event Date | Event Description |
Tuesday, November 5, 2024 | NEW APPLICATION ENTERED |
Tuesday, June 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, June 11, 2025 | ASSIGNED TO EXAMINER |
Wednesday, June 18, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, June 18, 2025 | NON-FINAL ACTION E-MAILED |
Wednesday, June 18, 2025 | NON-FINAL ACTION WRITTEN |
Monday, August 25, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, September 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, September 2, 2025 | ASSIGNED TO LIE |
Tuesday, September 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |